ReviewExperimental & molecular medicine2022

DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities.

Yasser Abuetabh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.